Skip to main content

Small Business Federal budget 2019: Ottawa loosens rules on R&D tax-credit plan

Ottawa is fixing a perceived flaw in its flagship research and development program by lifting a cap on how much income small companies can generate and still qualify for the tax credit.

Under the current rules, the government claws back the value of the credits when companies earn more than $500,000 a year and phases it out completely when they earn more than $800,000.

Experts say the policy has had the perverse effect of prompting companies to pay out income in salaries to employees rather than reinvesting in the business – just to stay below the income threshold.

Story continues below advertisement

“For small companies, it was a pretty common problem,” said Bruce Ball, vice-president of taxation for the Chartered Professional Accountants of Canada. “This will be a welcome change for them.”

The federal budget includes new spending in a range of areas including support for first-time homebuyers, ensuring seniors are enrolled in CPP and the further advancement of reconciliation.

The government’s Scientific Research and Experimental Development Program offers small Canadian-controlled private companies refundable tax credits of up to 35 per cent on the first $3-million a year they spend on R&D expenditures and non-refundable credits of 15 per cent for all other companies. The program costs the government roughly $3-billion a year and is used by more than 20,000 companies.

The budget eliminates the income test, effective with the current tax year. The government is keeping in place a $10-million limit on how much capital a company can have to qualify for the refundable credit.

Report an error Editorial code of conduct
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter